Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $2.0 million.

  • Niagen Bioscience's Prepaid Assets fell 319.66% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 319.66%. This contributed to the annual value of $2.5 million for FY2024, which is 130.61% up from last year.
  • Latest data reveals that Niagen Bioscience reported Prepaid Assets of $2.0 million as of Q3 2025, which was down 319.66% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Prepaid Assets ranged from a high of $4.3 million in Q3 2022 and a low of $972000.0 during Q2 2021
  • For the 5-year period, Niagen Bioscience's Prepaid Assets averaged around $2.2 million, with its median value being $2.1 million (2024).
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 14171.4% in 2022, then crashed by 4874.38% in 2023.
  • Over the past 5 years, Niagen Bioscience's Prepaid Assets (Quarter) stood at $1.9 million in 2021, then skyrocketed by 59.6% to $3.0 million in 2022, then fell by 17.43% to $2.4 million in 2023, then rose by 1.31% to $2.5 million in 2024, then dropped by 18.25% to $2.0 million in 2025.
  • Its Prepaid Assets was $2.0 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.4 million in Q1 2025.